1. Home
  2. ARGX vs VRT Comparison

ARGX vs VRT Comparison

Compare ARGX & VRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
  • VRT
  • Stock Information
  • Founded
  • ARGX 2008
  • VRT N/A
  • Country
  • ARGX Netherlands
  • VRT United States
  • Employees
  • ARGX N/A
  • VRT N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • VRT Industrial Machinery/Components
  • Sector
  • ARGX Health Care
  • VRT Technology
  • Exchange
  • ARGX Nasdaq
  • VRT Nasdaq
  • Market Cap
  • ARGX 40.4B
  • VRT 33.5B
  • IPO Year
  • ARGX 2017
  • VRT N/A
  • Fundamental
  • Price
  • ARGX $596.20
  • VRT $73.21
  • Analyst Decision
  • ARGX Strong Buy
  • VRT Strong Buy
  • Analyst Count
  • ARGX 20
  • VRT 15
  • Target Price
  • ARGX $699.56
  • VRT $125.07
  • AVG Volume (30 Days)
  • ARGX 465.0K
  • VRT 12.7M
  • Earning Date
  • ARGX 05-08-2025
  • VRT 04-23-2025
  • Dividend Yield
  • ARGX N/A
  • VRT 0.20%
  • EPS Growth
  • ARGX N/A
  • VRT 7.56
  • EPS
  • ARGX 12.78
  • VRT 1.28
  • Revenue
  • ARGX $2,248,205,000.00
  • VRT $8,011,800,000.00
  • Revenue This Year
  • ARGX $57.86
  • VRT $15.93
  • Revenue Next Year
  • ARGX $31.90
  • VRT $13.67
  • P/E Ratio
  • ARGX $43.64
  • VRT $57.20
  • Revenue Growth
  • ARGX 77.22
  • VRT 16.74
  • 52 Week Low
  • ARGX $352.77
  • VRT $53.60
  • 52 Week High
  • ARGX $678.21
  • VRT $155.84
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 51.80
  • VRT 45.76
  • Support Level
  • ARGX $583.00
  • VRT $68.33
  • Resistance Level
  • ARGX $610.06
  • VRT $73.47
  • Average True Range (ATR)
  • ARGX 24.42
  • VRT 6.17
  • MACD
  • ARGX 4.74
  • VRT 1.29
  • Stochastic Oscillator
  • ARGX 84.66
  • VRT 81.44

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

About VRT Vertiv Holdings LLC

Vertiv has roots tracing back to 1946 when its founder, Ralph Liebert, developed an air-cooling system for mainframe data rooms. As computers started making their way into commercial applications in 1965, Liebert developed one of the first computer room air conditioning, or CRAC, units, enabling the precise control of temperature and humidity. The firm has slowly expanded its data center portfolio through internal product development and the acquisition of thermal and power management products like condensers, busways, and switches. Vertiv has global operations today; its products can be found in data centers in most regions throughout the world.

Share on Social Networks: